HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - NYSE:HIMS - US4330001060 - Common Stock
41.03 USD
-0.49 (-1.18%)
41.2883 USD
+0.26 (+0.63%)
HIMS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of HIMS get a neutral evaluation. Nothing too spectacular is happening here. HIMS is valued quite expensive, but it does show an excellent growth. These ratings would make HIMS suitable for growth investing!
1. Profitability
1.1 Basic Checks
HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
In the past 5 years HIMS reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
HIMS has a better Return On Assets (10.31%) than 94.00% of its industry peers.
HIMS's Return On Equity of 34.41% is amongst the best of the industry. HIMS outperforms 96.00% of its industry peers.
HIMS has a Return On Invested Capital of 6.74%. This is in the better half of the industry: HIMS outperforms 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROIC | 6.74% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a Profit Margin of 9.62%. This is amongst the best in the industry. HIMS outperforms 92.00% of its industry peers.
HIMS's Operating Margin of 6.80% is fine compared to the rest of the industry. HIMS outperforms 67.00% of its industry peers.
HIMS has a better Gross Margin (76.20%) than 89.00% of its industry peers.
In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
HIMS has more shares outstanding than it did 1 year ago.
HIMS has more shares outstanding than it did 5 years ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
HIMS has an Altman-Z score of 6.13. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
HIMS has a better Altman-Z score (6.13) than 89.00% of its industry peers.
HIMS has a debt to FCF ratio of 8.11. This is a slightly negative value and a sign of low solvency as HIMS would need 8.11 years to pay back of all of its debts.
HIMS has a Debt to FCF ratio of 8.11. This is comparable to the rest of the industry: HIMS outperforms 55.00% of its industry peers.
A Debt/Equity ratio of 1.72 is on the high side and indicates that HIMS has dependencies on debt financing.
HIMS's Debt to Equity ratio of 1.72 is on the low side compared to the rest of the industry. HIMS is outperformed by 71.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Altman-Z | 6.13 |
ROIC/WACC0.74
WACC9.11%
2.3 Liquidity
A Current Ratio of 4.98 indicates that HIMS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.98, HIMS belongs to the top of the industry, outperforming 93.00% of the companies in the same industry.
A Quick Ratio of 4.46 indicates that HIMS has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.46, HIMS belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 |
3. Growth
3.1 Past
HIMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.73%, which is quite impressive.
HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 69.33%.
HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)69.33%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
The Earnings Per Share is expected to grow by 41.75% on average over the next years. This is a very strong growth
HIMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.53% yearly.
EPS Next Y11.88%
EPS Next 2Y22.49%
EPS Next 3Y23.43%
EPS Next 5Y41.75%
Revenue Next Year59.73%
Revenue Next 2Y38.12%
Revenue Next 3Y31.11%
Revenue Next 5Y22.53%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 75.98 indicates a quite expensive valuation of HIMS.
Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.06, HIMS is valued quite expensively.
The Price/Forward Earnings ratio is 50.64, which means the current valuation is very expensive for HIMS.
HIMS's Price/Forward Earnings ratio is in line with the industry average.
HIMS is valuated expensively when we compare the Price/Forward Earnings ratio to 32.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.98 | ||
| Fwd PE | 50.64 |
4.2 Price Multiples
HIMS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HIMS is more expensive than 61.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 77.6 | ||
| EV/EBITDA | 54.67 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 23.43% in the coming years.
PEG (NY)6.4
PEG (5Y)1.26
EPS Next 2Y22.49%
EPS Next 3Y23.43%
5. Dividend
5.1 Amount
HIMS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
41.03
-0.49 (-1.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.61%
Inst Owner Change9.31%
Ins Owners10.28%
Ins Owner Change-2.45%
Market Cap9.27B
Revenue(TTM)1.48B
Net Income(TTM)193.60M
Analysts67.62
Price Target49.8 (21.37%)
Short Float %32.95%
Short Ratio2.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.23%
Min EPS beat(2)10.29%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)185.99%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)152.2%
EPS beat(12)11
Avg EPS beat(12)111.23%
EPS beat(16)12
Avg EPS beat(16)74.99%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)6.75%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.23%
Revenue beat(12)9
Avg Revenue beat(12)2.03%
Revenue beat(16)13
Avg Revenue beat(16)3.23%
PT rev (1m)0%
PT rev (3m)-3.07%
EPS NQ rev (1m)-2.06%
EPS NQ rev (3m)-34.44%
EPS NY rev (1m)-2.1%
EPS NY rev (3m)-11.33%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-0.44%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.98 | ||
| Fwd PE | 50.64 | ||
| P/S | 4.61 | ||
| P/FCF | 77.6 | ||
| P/OCF | 35.45 | ||
| P/B | 16.48 | ||
| P/tB | 22.94 | ||
| EV/EBITDA | 54.67 |
EPS(TTM)0.54
EY1.32%
EPS(NY)0.81
Fwd EY1.97%
FCF(TTM)0.53
FCFY1.29%
OCF(TTM)1.16
OCFY2.82%
SpS8.91
BVpS2.49
TBVpS1.79
PEG (NY)6.4
PEG (5Y)1.26
Graham Number5.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 34.41% | ||
| ROCE | 8.53% | ||
| ROIC | 6.74% | ||
| ROICexc | 23.47% | ||
| ROICexgc | 35.76% | ||
| OM | 6.8% | ||
| PM (TTM) | 9.62% | ||
| GM | 76.2% | ||
| FCFM | 5.94% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 8.11 | ||
| Debt/EBITDA | 5.84 | ||
| Cap/Depr | 486.96% | ||
| Cap/Sales | 7.06% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 157.56% | ||
| Profit Quality | 61.73% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 4.46 | ||
| Altman-Z | 6.13 |
F-Score6
WACC9.11%
ROIC/WACC0.74
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y11.88%
EPS Next 2Y22.49%
EPS Next 3Y23.43%
EPS Next 5Y41.75%
Revenue 1Y (TTM)69.33%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year59.73%
Revenue Next 2Y38.12%
Revenue Next 3Y31.11%
Revenue Next 5Y22.53%
EBIT growth 1Y821.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year358.46%
EBIT Next 3Y94.49%
EBIT Next 5Y61.52%
FCF growth 1Y927.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y922.97%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 6 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 11.88% in the next year.